Related Experiment Video
Updated: Nov 15, 2025

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Post-COVID-19 Outbreak of Severe Kawasaki-like Multisystem Inflammatory Syndrome in Children
Sadia Shakeel1,2, Mohamed Azmi Ahmad Hassali1
1Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Pulau Pinang, Malaysia.
Insights
Multisystem inflammatory syndrome in children (MIS-C) is a rare but serious COVID-19 complication. It causes inflammation, potentially leading to severe cardiac issues in children, requiring further research into its triggers and risk factors.
Area of Science:
- Pediatric Infectious Diseases
- Immunology
- Cardiology
Background:
- The second wave of COVID-19 presents significant health challenges.
- While typically mild in children, COVID-19 can rarely cause severe illness with distinct manifestations.
- Multisystem inflammatory syndrome in children (MIS-C) is a rare, serious complication linked to COVID-19, emerging weeks post-infection.
Purpose of the Study:
- To highlight the critical nature of MIS-C in pediatric COVID-19 cases.
- To underscore the current lack of understanding regarding MIS-C triggers and risk factors.
- To emphasize the need for rigorous disease mapping and risk element identification for improved management.
Main Methods:
- Review of clinical manifestations of MIS-C in children.
- Analysis of the association between COVID-19 and MIS-C.
- Identification of potential inflammatory pathways involved in MIS-C.
Main Results:
- MIS-C involves inflammation in various body parts, significantly impacting the cardiovascular system.
- Cardiac complications, including inflammation of blood vessels supplying the heart, are noted in hospitalized children.
- The precise link and triggers between COVID-19 and MIS-C remain largely unidentified.
Conclusions:
- MIS-C represents a significant post-COVID-19 concern in children, particularly regarding cardiac health.
- Further research is crucial to elucidate the pathophysiology and triggers of MIS-C.
- Understanding MIS-C is essential for effective crisis navigation and pediatric patient management.
Abstract:
With the continuation of the second wave of a novel coronavirus disease (COVID-19), which is likely to be even more devastating, there are several associated health problems. COVID-19 is usually mild and non-fatal in children. However, in rare cases, children could severely be affected, and clinical manifestations may differ from adults. A multisystem inflammatory syndrome in children (MIS-C) is a rare but serious complication associated with COVID-19, initiated by an overactive immune response in kids that usually hits weeks after exposure to the COVID-19. MIS-C is a disorder in which inflammation could occur in different parts of the body. The disease puts pressure on the heart, as blood vessels leading towards the heart get inflamed and incapable of carrying adequate blood, hence producing cardiac complications in children hospitalised with MIS-C. The problem seems to be associated with COVID-19 in children; however, the association between MIS-C and COVID-19 is still unidentified. There is very little understanding of what triggers the MIS-C, which necessitates a rigorous mapping of the disease and associated risk elements for better disease management and navigating through this crisis.
More Related Videos
08:44Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis I: Introduction
Myocarditis IV: Nursing Management
Rheumatic Heart Disease I: Introduction